# Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

> **NCT02804750** · PHASE2 · COMPLETED · sponsor: **Corcept Therapeutics** · enrollment: 35 (actual)

## Conditions studied

- Cushing's Syndrome

## Interventions

- **DRUG:** CORT125134

## Key facts

- **NCT ID:** NCT02804750
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2019-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02804750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02804750, "Study to Evaluate CORT125134 in Participants With Cushing's Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02804750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*